105
Participants
Start Date
April 14, 2016
Primary Completion Date
October 23, 2017
Study Completion Date
October 24, 2017
BI 1026706
Placebo
Brussels-UNIV Brugmann -Horta, Brussels
Uzsoki Street Hospital, Budapest, Budapest
Leuven - UNIV UZ Leuven (Sint-Rafaël), Leuven
BAZ County Hospital, Ophtalmology Department, Miskolc, Miskolc
Univ.Szeged;Szent-Gyorgyi;Albert Heal.Cent.Ophtalmology Dep, Szeged
Attikon, Panepistimiako Geniko Nosokomeio, Athens
HOP Nord, Marseille
Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela
University of Patras Medical School, Pátrai
Hospital La Paz, Madrid
HOP Pierre Paul Riquet, Toulouse
Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen
HOP Hôtel-Dieu, Nantes
Hospital Clínico Universitario de Valladolid, Valladolid
Augen Zentrum Nordwest, Ahaus, Ahaus
Universitätsklinikum Aachen, AöR, Aachen
Augenarzt Dr. Dunker und Kollegen, Troisdorf, Troisdorf-Sieglar
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
University General Hospital of Heraklion, Herakleion,Crete
Universitätsklinikum Tübingen, Tübingen
HOP Lariboisière, Paris
Hosp National 15-20, Ophtalmo, Paris, Paris
Universitätsklinikum Ulm, Ulm
Kamppeter Augenzentrum, Bayreuth, Bayreuth
Hospital de Braga-Escala Braga, Braga
AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra
Centro Hospitalar São João,EPE, Porto
Hospital de Vila Franca de Xira, Vila Franca de Xira
Hospital Dos de Maig, Barcelona
Hospital Vall d'Hebron, Barcelona
Frimley Park Hospital, Frimley
Royal Surrey County Hospital, Guildford
Moorfields Eye Hospital, London
Royal Victoria Infirmary, Newcastle upon Tyne
Southampton General Hospital, Southampton
Lead Sponsor
Boehringer Ingelheim
INDUSTRY